Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
PF-06882961 was a partial agonist in recruiting Arr2 (EC 50 = 490 nM, E max = 36%), while exenatide (Arr2 EC 50 = 9.0 nM, E max = 75%) and liraglutide (Arr2 EC 50 = 20 nM, E max = 99%) were respectively 54- and 23-fold more potent with greater E max values
Moderate side effects may include constipation or diarrhea, upset stomach, nausea or vomiting, headaches, abdominal pain, fatigue, and low blood sugar
Body weight and composition contribute to normal population variability in pharmacokinetics
For research teams who want to expand their projects beyond a single vial, the broader BPC lineup at Pure Tested Peptidesincluding TB-500 vials, blended BPC-157/TB-500 tools, and capsule formatsoffers multiple ways to design comparison studies and long-term projects
Nhng u bit ngoi kia cn nhiu la chn hn th c v mi m, phc hi mnh m v nhiu tim nng bt ng khc cho ln da
Qualification process for drug development tools guidance for industry and FDA staff
